series-c-plus
Stage
4
Investors
About
Theraclion develops and markets an echotherapy solution, using high-intensity focused ultrasound (HIFU), for the non-invasive treatment of benign and malignant tumors. Their primary applications include breast fibroadenomas and thyroid nodules.
Explore Theraclion's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.